Le Lézard
Classified in: Health
Subjects: MAT, PVP

CGOC Strategic Partner Battalion Consol Corp. Invests $1.3 Million in Compassionate Certification Centers


$1.3 Million Hybrid Equity Investment through Private Placement

Amplifies Ability to Drive Expansion in Medical Cannabis Sector

PITTSBURGH, June 21, 2018 /CNW/ - Compassionate Certification Centers ("CCC"), Pennsylvania's largest independent physician cannabis health care organization, today announced that Battalion Consol Corp. ("Battalion"), has entered into a definitive agreement to invest $1.3 million into CCC through a direct private placement of hybrid equity securities. The investment will carry an interest rate of 14% per annum, will include warrants to purchase 10% of CCC, and a 2.9% gross revenue royalty.

"This capital injection will allow Compassionate Certification Centers to leverage its first mover advantage and crystalize a dominate position in the Pennsylvania market," said John Paul Jeffrey, Managing Director, Battalion. "We have already identified several strategic partnership opportunities between CCC and our portfolio companies and partners that will immediately and dramatically accelerate growth, revenue, and margins."

"Our partnership with Battalion Consol will allow us to expand our outstanding patient certification and care programs. We could not be more pleased," said Melonie Kotchey, COO of Compassionate Certification Centers. "Beyond funding, their industry reach and connections have opened several opportunities for us to expand offerings and optimize operations."

The fifth-largest state in the country, Pennsylvania dispensary sales have the potential to exceed $100 million annually in the next few years.

About Compassionate Certification Centers®

Compassionate Certification Centers is a unique company devoted to assisting U.S. citizens who desire access to medical marijuana in a way that respects the laws and guidelines of each state law. Our approach involves convenient cannabis treatment center locations, provides nursing CBD/THC consultation and care, and proof of compliance for the respective Department of Health or Pharmacy depending on the state.

About Battalion Consol Corp.

BATTALION CONSOL CORP. is a private equity investment firm and strategic partner of Cannabis Growth Opportunity Corp. (CSE:CGOC).

SOURCE Battalion Consol Corp.


These press releases may also interest you

at 07:10
Science Corporation ("Science"), a leader in brain-computer interface ("BCI") technology and the developer of the Science Eye, has acquired the IP and related assets for the PRIMA retinal implant, developed by Pixium Vision SA ("Pixium") of France, a...

at 07:05
GlycoMimetics, Inc. , today announced that it will host a conference call and webcast to report first quarter 2024 financial results on Thursday, May 9, 2024 at 8:30 a.m. ET. To access the call by phone, please go to this registration link and you...

at 07:05
Harrow , a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March 31, 2024, on Monday, May 13, 2024, after the market close. The Company will also post its first...

at 07:05
Mind Medicine (MindMed) Inc. , (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it will present detailed results from its phase 2b study...

at 07:05
Mission Bio, a leader in single-cell multiomic solutions for precision medicine, today announced the launch of a new single-cell capability that enhances our understanding of translocations (chromosomal rearrangements) in gene-edited therapies....

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra) will host the Aldeyra 2024 Research & Development Day with investors and financial analysts in New York City to present recent pipeline developments relating to the RASP modulation platform and ADX-2191 for the...



News published on and distributed by: